VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Maravai LifeSciences Holdings, Inc. (MRVI) Total Return Calculator with Dividends Reinvested

Maravai LifeSciences Holdings, Inc.

Popular:

The total return for Maravai LifeSciences Holdings, Inc. (MRVI) stock is +85.85% over the past 12 months. So far it's up 15.88% this year. The 5-year total return is -89.39%, meaning $10,000 invested in MRVI stock 5 years ago would be worth $1,061 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in MRVI 1 year ago, it would be worth $19,034 today — you'd have gained $9,034.

With Dividends Reinvested$19,034+90.34%

Price Only (No DRIP)$19,034+90.34%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in MRVI

1Y$18,585+$8,585 (+85.8%)85.8% CAGR

3Y$2,835-$7,165 (-71.7%)-34.3% CAGR

5Y$1,061-$8,939 (-89.4%)-36.2% CAGR

10Y$1,320-$8,680 (-86.8%)-18.3% CAGR

15Y$1,320-$8,680 (-86.8%)-12.6% CAGR

20Y$1,320-$8,680 (-86.8%)-9.6% CAGR

30Y$1,320-$8,680 (-86.8%)-6.5% CAGR

Maravai LifeSciences Holdings, Inc. did not pay dividends during this period. Total return = price return.

Loading MRVI total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+15.88%	—	+15.88%	—	$11,588
1Y	+85.85%	85.85%	+85.85%	—	$18,585
3Y	-71.65%	-34.31%	-71.65%	—	$2,835
5Y	-89.39%	-36.16%	-89.39%	—	$1,061
10Y	-86.80%	-18.33%	-86.80%	—	$1,320
15Y	-86.80%	-12.63%	-86.80%	—	$1,320
20Y	-86.80%	-9.63%	-86.80%	—	$1,320
30Y	-86.80%	-6.53%	-86.80%	—	$1,320

Risk & Highlights

Best Year+52.36%2021

Worst Year-64.01%2022

Max Drawdown-29.76%2025-07-10 → 2025-08-07 · Recovered 2025-09-16

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+4.71%	+4.71%	—	+0.41%	+4.3pp
2025	-40.80%	-40.80%	—	+16.64%	-57.4pp
2024	-19.14%	-19.14%	—	+24.00%	-43.1pp
2023	-52.15%	-52.15%	—	+24.81%	-77.0pp
2022	-64.01%	-64.01%	—	-19.95%	-44.1pp

MRVI outperformed the S&P 500 by 55.48pp over the past year (+85.85% vs +30.37%).

Loading summary...

MRVI Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
MRVIMaravai LifeSciences Holdings, Inc.	$436M	+36.3%	+15.9%	+85.8%	—	-71.7%	-89.4%	-86.8%
AZTAAzenta, Inc.	$855M	-14.5%	-44.4%	-26.5%	—	-59.1%	-81.0%	+123.4%
NUVLNuvalent, Inc.	$7.5B	+0.1%	+1.5%	+53.5%	—	+171.2%	+446.1%	+446.1%
BCABBioAtla, Inc.	$5M	-6.7%	-83.7%	-80.6%	—	-97.3%	-99.8%	-99.7%
ALNYAlnylam Pharmaceuticals, Inc.	$39.5B	-7.4%	-26.1%	+7.0%	—	+40.9%	+125.4%	+411.9%
ILMNIllumina, Inc.	$21.1B	+9.7%	+3.2%	+81.7%	—	-27.1%	-62.8%	+0.7%
PACBPacific Biosciences of California, Inc.	$498M	+14.6%	-10.3%	+46.0%	—	-86.5%	-93.4%	-81.3%
TWSTTwist Bioscience Corporation	$3.6B	+16.8%	+80.7%	+78.6%	—	+336.9%	-49.9%	+318.1%
BEAMBeam Therapeutics Inc.	$3.2B	+28.5%	+16.0%	+93.9%	—	-5.6%	-55.6%	+67.8%
NTLAIntellia Therapeutics, Inc.	$1.6B	+1.2%	+48.9%	+88.1%	—	-68.3%	-79.8%	-42.9%
CRSPCRISPR Therapeutics AG	$5.1B	+5.5%	-2.5%	+53.1%	—	-6.3%	-51.3%	+272.0%

Compare:MRVI vs AZTA MRVI vs NUVL MRVI vs BCAB MRVI vs AZTA vs NUVL

About MRVI Dividend Returns

Maravai LifeSciences Holdings, Inc. (MRVI) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of MRVI over the past year?

Maravai LifeSciences Holdings, Inc. (MRVI) delivered a return of 85.85% over the past year. Since MRVI does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in MRVI be worth today?

A $10,000 investment in Maravai LifeSciences Holdings, Inc. one year ago would be worth $18,585 today, representing a gain of $8,585.

Q3Does MRVI pay dividends?

Maravai LifeSciences Holdings, Inc. (MRVI) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For MRVI, the total return equals the price-only return.

Q4Did MRVI beat the S&P 500?

Yes, Maravai LifeSciences Holdings, Inc. (MRVI) outperformed the S&P 500 by 55.48 percentage points over the past year. MRVI delivered a total return of 85.85%, compared to the S&P 500's 30.37%. This 55.48pp alpha means investors in MRVI earned more than a passive S&P 500 index fund.

Q5What is MRVI's worst drawdown?

Maravai LifeSciences Holdings, Inc. (MRVI) experienced a maximum drawdown of -29.76% over the past year, declining from its peak on 2025-07-10 to its trough on 2025-08-07. The stock recovered to its prior peak by 2025-09-16. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is MRVI's long-term total return over 10, 20, or 30 years?

Here are Maravai LifeSciences Holdings, Inc. (MRVI)'s long-term returns with dividends reinvested. Over 10 years, the total return is -86.8% (-18.3% CAGR) — $10,000 would have grown to $1,320. Over 20 years: -86.8% total return (-9.6% CAGR) — $10,000 → $1,320. Over 30 years: -86.8% total return (-6.5% CAGR) — $10,000 → $1,320. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was MRVI's best and worst year?

Maravai LifeSciences Holdings, Inc.'s best calendar year was 2021 with a total return of 52.4%. Its worst year was 2022 with a total return of -64.0%. This range shows the volatility investors should expect — the difference between the best and worst year is 116.4 percentage points.